All News

An ounce of prevention

Across the country, pharmacists are helping prevent the spread of disease in their communities by advocating and administering vaccinations to keep people healthy.

Continuing shortages of generic oncology chemotherapeutic agents dangerously limit patient-care choices, affect clinical outcomes, and stretch already tight pharmacy resources.

As healthcare moves swiftly toward a more comprehensive electronic platform, pharmacies will be required to upgrade their claim submission standard from NCPDP 5.1 to NCPDP D.0, an updated version of the HIPAA standard for pharmacy claims transactions.

Take your best shot

Very soon the pharmacist will be the primary care provider for all colds, stuffy noses, sore throats, and coughs. This is your chance. Take it or leave it.

New Products

A survey of new Rx, new generic, and new OTC products

Advocates are hoping for a new push in Congress to control rogue online pharmacies, according to Bryan A. Liang, professor at the University of California, San Diego, School of Medicine and vice president of the Partnership for Safe Medicine.

A new report from the Institute of Medicine recommends that 8 preventive health services for women be added to the services that health plans will cover at no cost to patients under the Patient Protection and Affordable Care Act of 2010.

The American Pharmacists Association (APhA) is accepting nominations for its annual profession-wide awards and honors. The awards will be presented at the APhA Annual Meeting and Exposition in New Orleans, March 9-12, 2012. The awards represent the pharmacy profession?s most comprehensive recognition program.

Pharmacies can play a valuable role in helping patients prepare for the upcoming flu season. That includes administering influenza vaccinations, according to results of a public-private partnership campaign in Palm Beach, Fla. The National Association of Chain Drug Stores highlighted the results of the partnership in a report it co-authored that was published in the September/October issue of the Journal of Public Health Management and Practice.

FDA issued a warning last week that chronic high doses (400 mg/day to 800 mg/day) of fluconazole (Diflucan) during the first trimester of pregnancy may be associated with specific birth defects in infants. However, according to the Safety Alert released August 3, the risk does not appear to be associated with the single low dose of fluconazole (150 mg) that is used to treat vaginal yeast infection (candidiasis).

Programs designed to support the care of older patients as they make the transition from the hospital to outside clinicians and healthcare settings are associated with reduced rates of hospital readmissions, according to 2 reports in the July 25 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

FDA has approved a subcutaneous (SC) formulation of abatacept (Orencia, Bristol-Myers Squibb) for the treatment of adults with moderate-to-severe rheumatoid arthritis (RA). It is the first biologic available in both SC and intravenous formulations for the treatment of RA.

FDA has issued a 90-day extension of the action date for Pfizer?s Prevnar 13 (Pneumococcal 13-valent Conjugate Vaccine [Diphtheria CRM197 Protein]) in adults 50 years of age and older.

Johnson and Johnson has announced plans for new dosing instructions that lower the maximum daily dose for single-ingredient Extra Strength Tylenol (acetaminophen) products sold in the United States from 8 pills per day (4,000 mg) to 6 pills per day (3,000 mg).